The pharmaceutical and chemical giant has had a difficult year. The settlement of the glyphosate lawsuits in the USA and billions in write-offs in the agricultural business resulted in a…
Read More
With its largest acquisition to date in the biotech sector, Bayer aims to become a leading player in gene and cell therapy. The Leverkusen-based group is taking over the non-listed…
Read MorePage 1 of 1